Search

Your search keyword '"Mekinian A"' showing total 2,397 results

Search Constraints

Start Over You searched for: Author "Mekinian A" Remove constraint Author: "Mekinian A"
2,397 results on '"Mekinian A"'

Search Results

3. Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study

4. Prevalence and association of placental lesions with obstetrical features and outcome: data from French prospective studyAJOG Global Reports at a Glance

5. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

6. Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study

7. Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National Cohort

8. The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study

11. Clinical spectrum and outcome of Takayasu's arteritis in children

13. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

15. Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1–phase 2a study

16. Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease

17. Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)

18. Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases

19. The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial

20. Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial

21. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

23. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trialsResearch in context

24. History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosis

25. Factors associated with satisfaction with social roles and activities among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort cross-sectional study

26. Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation

27. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

28. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?

29. Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease

31. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children

32. Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients

33. Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study

34. Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation

35. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

37. A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML

39. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

40. Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10‐Item Connor‐Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study

41. Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale‐6: A Scleroderma Patient‐Centered Intervention Network (SPIN) Study

42. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome

43. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients

45. Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional studyResearch in context

46. Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial

48. Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients

49. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

50. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

Catalog

Books, media, physical & digital resources